Slow jogging for fatty liver disease
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests if slow jogging in place can help people with a common type of fatty liver disease (MASLD). You would be asked to follow a regular, gentle jogging routine and have your liver health checked over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with MASLD (fatty liver linked to metabolic issues).
- You are willing to try slow jogging in place as an exercise program.
- You have not had unstable weight changes (more than 8-9 pounds lost or gained) in the last 3 months.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a high-intensity exercise program can improve liver function and insulin sensitivity in people with MASLD (a type of fatty liver disease). It may help you if you are looking for a non-drug way to manage your condition.
This study tests whether a program of physical activity can reduce fat in the muscles and liver of people with MASLD, a type of fatty liver disease linked to metabolism. It looks at how exercise might help improve liver health.
This study tests if different types of exercise can reduce fat in the liver for people with metabolic fatty liver disease. It might help if you are looking for a non-drug way to improve your liver health.
This study tests whether a live-streamed exercise program can improve liver health in pregnant women who have MASLD (a type of fatty liver disease). If you join, you'll be asked to follow exercise sessions at home while researchers track your liver health.
This trial tests whether a digital diet and exercise program can reduce liver scarring in people with MASLD (fatty liver disease not caused by alcohol). You would use an app on your smartphone to follow the program at home.
This trial tests new medicines for adults with fatty liver disease (MASLD) that has already caused some liver scarring. It aims to see if these drugs can help prevent the liver disease from getting worse.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.